SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-14-144301
Filing Date
2014-04-15
Accepted
2014-04-15 16:58:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B3 d713336d424b3.htm 424B3 870080
2 GRAPHIC g630905dsp_006.jpg GRAPHIC 117600
3 GRAPHIC g630905dsp_007.jpg GRAPHIC 128534
4 GRAPHIC g630905dsp_008.jpg GRAPHIC 143173
5 GRAPHIC g630905dsp_009.jpg GRAPHIC 128857
6 GRAPHIC g630905dsp_011.jpg GRAPHIC 129822
7 GRAPHIC g630905dsp_015.jpg GRAPHIC 114162
8 GRAPHIC g630905dsp_023.jpg GRAPHIC 231902
  Complete submission text file 0001193125-14-144301.txt   2241892
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-182447 | Film No.: 14765597
SIC: 2834 Pharmaceutical Preparations